Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Objective.Deep learning has significantly advanced low-count positron emission tomography (PET) denoising. However, models trained on specific distributions often yield biased outputs when applied to scans with different activity distributions caused by anatomical and physiological variations (distribution shifts). Existing methods fail to generalize well across these scan-wise variations. Our goa...
By 2050, nearly 20% of the global population will exceed 60 years old, experiencing compromised physiological and functional abilities, neurological disorders, and sarcopenia. Geroscience has evolved immensely through OMICS approaches and high-throughput technologies, generating massive datasets requiring efficient management, annotation, and storage. This highlights the need for user-friendly dat...
This study aimed to investigate the prevalence of screening-positive mild cognitive impairment (s-MCI) and to develop a parsimonious prediction model ...
Interventions targeting social and health-related risk factors are thought to reduce the risk of cognitive decline and dementia in older age. Despite ...
Whether individual-level cognitive trajectories in Parkinson's disease are predictable remains unresolved. Here, we provide convergent evidence that m...
BACKGROUND: Delirium is a frequent manifestation of acute brain dysfunction in critically ill patients with bloodstream infections (BSI). While the as...
BACKGROUND: Early identification of autism spectrum disorder (ASD) is essential for improving developmental outcomes but remains challenging due to di...
Early detection and biological characterization of Alzheimer's disease (AD) remain challenging, as current diagnostic approaches rely on invasive cere...
Semi-quantitative positron emission tomography (PET) analysis, particularly Centiloid and CenTauRz scaling, is essential for Alzheimer's disease (AD) ...
Artificial Intelligence (AI) has become integral to the research of neurological diseases due to the rapid expansion of neuroimaging, clinical, physio...
BACKGROUND: Stanozolol, a synthetic anabolic androgenic steroid (AAS) widely abused to enhance performance, has poorly defined toxicological mechanism...
BACKGROUND: Dementia caregiving entails chronic, fluctuating stress with downstream risks to caregivers' mental health and quality of care. Mindfulnes...
OBJECTIVE: This study uses bibliometric analysis and knowledge mapping methods to systematically explore the emerging research frontiers and developme...
As a progressive neurodegenerative disorder, Alzheimer's disease (AD) requires early and accurate diagnosis to delay pathological progression and impr...
Targeting the intrinsically disordered N-terminal domain of the androgen receptor (AR-NTD) represents a promising strategy to overcome resistance in p...
Neurodegenerative diseases, such as Mild Cognitive Impairment (MCI) and Alzheimer's, pose significant challenges due to their progressive nature and l...
BACKGROUND: Atherosclerosis is a major cause of ischemic stroke and is characterized by complex immune-metabolic dysregulation. VAV3, a Rho guanine nu...
BACKGROUND: In an attempt to overcome the space-time limitations of traditional training we used a new telemedicine home-training model (Videotraining...
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are described as a disease continuum, given their shared clinical, genetic and p...
The use of amyloid PET to assess patient suitability of disease-modifying drugs for Alzheimer disease is increasing. This study aimed to synthesize am...